Globus Medical buys Synaptive Medical to expand in cranial neurosurgery

What's the deal? Globus MedicalDealroom has a profile for this one. Try Dealroom → has acquired Synaptive MedicalDealroom has a profile for this one. Try Dealroom →, a medical technology company focused on complex cranial procedures, deepening its presence in cranial neurosurgery. The deal, announced on November 3, closed on August 4, 2026, through a court-appointed receivership process. Terms were not disclosed.

What each side brings: Globus Medical is a musculoskeletal technology company spanning spine, orthopedic trauma, joint reconstruction, and enabling technologies. Synaptive develops surgical visualization, navigation, planning, and MRI tools, plus relationships with leading neurosurgical centers.

What's the endgame? Globus wants to combine Synaptive's planning and visualization technology with its Excelsius ecosystem to build integrated procedural solutions for neurosurgeons. "This acquisition builds on the foundation we have established in cranial neurosurgery and accelerates our growth in this important market," said chief executive officer Keith Pfeil.

What could go wrong? The receivership route signals Synaptive faced financial distress, so Globus inherits the task of stabilising the business. Its immediate priority is continuity: it has begun customer outreach and is setting up service and support for the installed base while it finalises a long-term commercial strategy.

The signal: The deal reflects medical device makers broadening beyond their core markets into enabling technologies, where surgical navigation and planning are becoming central to how procedures are sold. For Globus, cranial neurosurgery is a growth adjacency to its spine and orthopedic roots — and a distressed-asset purchase is a low-cost way to enter it.

Read more: business.theantlersamerican.com

Image credit: Generated with Gemini